Anne Douar, Chief Development Officer of Vivet Therapeutics, will give a presentation (“Finding the Right Dose From Mice to Human: A Complex Equation”) during the 2nd Annual Gene Therapy for Rare Disorders Europe conference in London on Oct. 24th at 11am.